Mobile Site ›
Print Friendly View

Test ID: GHIVS    
HIV-1 Ultrasensitive Genotypic Drug Resistance Mutation Analysis, Plasma

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Identification of HIV-1 genotypic mutations associated with resistance to nucleotide reverse-transcriptase inhibitors, nonnucleotide reverse-transcriptase inhibitors, and protease inhibitors in patients with HIV-1 viral loads between 200 and 1,000 copies/mL

 

Guiding change of anti-HIV-1 treatment regimens in patients with HIV-1 viral loads between 200 and 1,000 copies/mL

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

See HIV Treatment Monitoring Algorithm in Special Instructions.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Followed by DNA Sequencing
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

HIV-1 Ultra Genotyp Drug Resist, P

Aliases Lists additional common names for a test, as an aid in searching

AIDS (acquired immune deficiency syndrome)
HIV Genotyping
HIV Resistance
HIV-1 Drug Resistance Mutation Analysis
HIV-1 Genotyping for Drug Resistance
HIV-1 Mutation Analysis
Human Immunodefiency Virus (HIV)